Carmot therapeutics announces significant leadership team expansion with anne phillips, md, frcpc previously svp novo nordisk, joining the board of directors and heather turner, j.d. joining as coo

Berkeley, calif.--(business wire)--carmot therapeutics, inc. (berkeley, ca), a clinical-stage biotechnology company applying its proprietary drug discovery platform, chemotype evolution, to discover and develop disease-modifying therapies in metabolic disease and cancer, announced today an expansion of its board of directors and executive leadership team. anne phillips, md, frcpc joins carmot's board and heather turner, j.d., joins as chief operating officer. “we are delighted to welcome anne p
NVO Ratings Summary
NVO Quant Ranking